BeStock  
Stocks › Biotechnology › PTCT

PTC Therapeutics PTCT

US equityMarket cap rank #2094Biotechnology
$56.42 −$1.91 (-3.27%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $56.99 +1.01%
Open$58.78
Prev close$58.33
Day range$56.18 – $58.96
Volume952.6K
Market cap$4.71B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$357.81M+69.6% YoY
Operating profit$25.11M+620.0% YoY
Net profit-$51.69M-425.2% YoY
Diluted EPS-$0.62-410.0% YoY
Free cash flow-$31.33M+90.3% YoY
Operating cash flow-$25.31M

Revenue, last 8 quarters

$213.2MDec '24$1.2BMar '25$178.9MJun '25$211.0MSep '25$164.7MDec '25$272.6MMar '26$360.5MJun '26$357.8MSep '26

Net profit, last 8 quarters

$-65.9MDec '24$866.6MMar '25$-64.8MJun '25$15.9MSep '25$-135.0MDec '25$-2.8MMar '26$83.5MJun '26$-51.7MSep '26

Diluted EPS by quarter

-0.85Dec '2410.04Mar '25-0.83Jun '250.20Sep '25-1.67Dec '25-0.03Mar '260.92Jun '26-0.62Sep '26

Free cash flow by quarter

$-36.5MDec '24$867.6MMar '25$-62.3MJun '25$-322.6MSep '25$-71.6MDec '25$-60.4MMar '26$122.0MJun '26$-31.3MSep '26

Annual revenue

$380.8MFY20$538.6MFY21$698.8MFY22$937.8MFY23$806.8MFY24$1.7BFY25

Profitability & balance sheet

Gross margin93.2%
Operating margin12.0%
Net margin-9.2%
Return on assets-3.6%
Current ratio3.27
Liabilities / assets106.0%
Cash & investments$2.13B
Total debt$621.82M
Net cash (debt)$1.51B

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Sephience$181.89M 50.8%
  • Royalty revenue$81.68M 22.8%
  • Translarna$48.51M 13.6%
  • Emflaza$25.09M 7.0%
  • Upstaza/Kebilidi$14.55M 4.1%
  • All other products$5.85M 1.6%
  • Collaboration and license revenue$229,000.00 0.1%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $357.81M $360.52M $272.55M $1.73B $164.68M
Total Operating Revenue $357.81M $360.52M $272.55M $1.73B $164.68M
Cost of Revenue $23.66M $19.92M $28.03M $47.01M $6.95M
Gross Profit $334.14M $340.60M $244.52M $1.68B $157.73M
Operating Expense $309.03M $191.62M $198.64M $827.13M $239.35M
Selling and Admin Expenses $80.08M $80.63M $86.18M $347.14M $96.87M
Research & Development $216.35M $99.15M $100.87M $455.25M $133.13M
Depreciation & Amortization & Depletion $12.60M $11.84M $11.58M $24.74M $9.35M
-Depreciation & Amortization $12.60M $11.84M $11.58M $24.74M $9.35M
Operating Profit $25.11M $148.98M $45.89M $856.51M -$81.62M
Net Non-Operating Interest Income (Expense) -$45.87M -$48.48M -$49.03M -$152.23M -$55.19M
Non-Operating Interest Expense $45.87M $48.48M $49.03M $152.23M $55.19M
Other Income (Expense) -$20.34M -$2.95M $682,000.00 -$7.66M -$2.27M
Special Income (Charges) -$19.26M $0.00 -$927,000.00 $10.43M $10.28M
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00 -$800,000.00 $0.00
-Less:Impairment of Capital Assets $0.00 $0.00 $927,000.00 -$9.63M -$10.28M
-Less:Other Special Charges $19.26M – – – –
Other Non-Operating Income (Expenses) -$1.07M -$2.95M $1.61M -$18.09M -$12.55M
Pretax Profit -$41.09M $97.55M -$2.46M $696.62M -$139.08M
Tax $10.61M $14.05M $347,000.00 $13.98M -$4.12M
Net Profit -$51.69M $83.50M -$2.81M $682.64M -$134.97M
Profit from Continuing Operations -$51.69M $83.50M -$2.81M $682.64M -$134.97M
Net Income to Parent Company -$51.69M $83.50M -$2.81M $682.64M -$134.97M
Net Income to Common Stockholders -$51.69M $83.50M -$2.81M $682.64M -$134.97M
Basic EPS -$0.62 $1.01 -$0.03 $8.58 -$1.67
Diluted EPS -$0.62 $0.92 -$0.03 $8.58 -$1.67

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $3.21B $3.25B $2.87B $2.90B $2.90B
Total Current Assets $2.54B $2.62B $2.25B $2.27B $2.27B
Cash and Cash Equivalents & Short-Term Investments $2.13B $2.23B $1.89B $1.95B $1.95B
-Cash and Cash Equivalents $508.89M $1.05B $833.99M $984.65M $984.65M
-Short Term Investments $1.62B $1.18B $1.06B $960.72M $960.72M
Receivables $238.07M $239.04M $219.92M $181.62M $181.62M
-Accounts Receivable $238.07M $239.04M $219.92M $181.62M $181.62M
Inventory $109.33M $91.35M $75.57M $79.65M $79.65M
Other Current Assets $62.47M $57.88M $66.05M $67.31M $67.31M
Total Non-Current Assets $669.93M $633.12M $615.10M $624.82M $624.82M
Net PPE $122.28M $126.27M $129.43M $135.42M $135.42M
-Gross PPE $122.28M $126.27M $129.43M $182.42M $182.42M
Goodwill and Other Intangible Assets $526.03M $485.27M $463.03M $471.09M $471.09M
-Goodwill $82.34M $82.34M $82.34M $82.34M $82.34M
-Other Intangible Assets $443.69M $402.93M $380.68M $388.75M $388.75M
Other Non-Current Assets $21.63M $21.58M $22.65M $18.30M $18.30M
Total Liabilities $3.40B $3.42B $3.05B $3.10B $3.10B
Total Current Liabilities $776.08M $771.07M $923.60M $968.43M $968.43M
Payables $121.59M $70.45M $25.48M $50.58M $50.58M
-Accounts Payable $41.59M $40.45M $25.48M $45.49M $45.49M
-Total Tax Payable $0.00 $0.00 $0.00 $4.68M $4.68M
-Other Payable $80.00M $30.00M – $416,000.00 $416,000.00
Current Accrued Expenses $170.49M $152.93M $127.60M $127.76M $127.76M
Short-Term Debt and Capital Lease Obligation $14.21M $73.42M $305.02M $585.12M $585.12M
-Current Capital Lease Obligation $14.21M $17.97M $18.08M $15.48M $15.48M
Current Provisions $100.32M $119.56M $126.13M $129.20M $129.20M
Current Deferred Liabilities $1.98M $1.19M $498,000.00 $2.04M $2.04M
Other Current Liabilities $319.08M $314.22M $305.04M – –
Total Non-Current Liabilities $2.62B $2.64B $2.13B $2.14B $2.14B
Long Term Debt and Capital Lease Obligation $621.82M $623.05M $90.07M $2.12B $2.12B
-Long Term Debt $536.27M $535.52M – $2.03B $2.03B
-Long Term Capital Lease Obligation $85.55M $87.53M $90.07M $96.58M $96.58M
Other Non-Current Liabilities $2.00B $2.02B $2.04B $13.70M $13.70M
Total Equity -$191.21M -$165.36M -$180.47M -$205.31M -$205.31M
Stockholders' Equity -$191.21M -$165.36M -$180.47M -$205.31M -$205.31M
Capital Stock $82,000.00 $82,000.00 $81,000.00 $80,000.00 $80,000.00
-Common Stock $82,000.00 $82,000.00 $81,000.00 $80,000.00 $80,000.00
Additional Paid-In Capital $2.74B $2.71B $2.78B $2.75B $2.75B
Retained Earnings -$2.94B -$2.88B -$2.97B -$2.96B -$2.96B
Gains/Losses Not Affecting Retained Earnings $2.55M $6.02M $8.47M $10.50M $10.50M
-Current Debt – $55.45M $286.94M $569.63M $569.63M
-Accumulated Depreciation – – – -$46.99M -$46.99M
Long Term Accounts Payable and Other Payables – – – $0.00 $0.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$25.31M $129.11M -$59.04M $711.20M -$34.27M
Net cash flow from continuing operations -$25.31M $129.11M -$59.04M $711.20M -$34.27M
Net Income from Continuing Operations -$51.69M $83.50M -$2.81M $682.64M -$134.97M
Gain/Loss from Continuing Operations $18.52M $1.35M $40,000.00 $10.75M $5.82M
Depreciation & Depletion & Amortization $16.82M $15.87M $15.41M $38.82M $12.90M
Other Non-Cash Items -$13.26M -$234,000.00 $20.93M -$20.98M -$22.19M
Change in Working Capital -$14.01M $10.19M -$110.70M -$47.88M $91.11M
-Change in Receivables $42,000.00 -$19.73M -$40.39M -$10.15M $22.21M
-Change in Inventory -$18.12M -$15.86M $2.64M -$53.90M -$26.78M
-Change in Prepaid Assets -$4.74M $9.37M -$408,000.00 -$34.18M -$21.81M
-Change in Payables and Accrued Expense $10.69M $37.50M -$68.71M $71.74M $108.08M
-Change in Other Current Liabilities -$2.70M -$1.82M -$2.31M -$17.40M $9.10M
-Change In Other Working Capital $811,000.00 $718,000.00 -$1.52M -$4.00M $300,000.00
Net cash flow from investing -$442.41M -$122.56M -$93.74M -$861.98M $34.01M
Net Cash Flow from Continuing Investing Activities -$442.41M -$122.56M -$93.74M -$861.98M $34.01M
Net PPE Purchase and Sale -$2.66M -$2.19M -$1.20M -$8.79M -$2.37M
Net Intangibles Purchase and Sale -$3.37M -$4.95M -$156,000.00 -$291.15M -$34.92M
Net Investment Purchase and Sale -$436.39M -$115.41M -$92.38M -$562.04M $71.30M
Financing Cash Flow -$73.24M $211.88M $6.40M $331.09M $302.50M
Net Cash Flow from Continuing Financing Activities -$73.24M $211.88M $6.40M $331.09M $302.50M
Net Issuance Payments Of Debt -$77.76M – – -$1.61M $0.00
Proceeds from Stock Option Exercised $5.35M $16.40M $6.40M $99.05M $62.50M
Net Other Financing Charges -$822,000.00 – – $233.66M $240.00M
Ending Cash Balance $525.34M $1.07B $850.44M $998.33M $998.33M
Net Change in Cash -$540.96M $218.44M -$146.38M $180.31M $302.24M
Beginning Cash Balance $1.07B $850.44M $998.33M $795.32M $686.30M
Effect of Exchange Rate Changes -$38,000.00 -$2.54M -$1.52M $22.71M $9.80M
Free Cash Flow -$31.33M $121.97M -$60.40M $411.18M -$71.56M
Deferred Tax – – -$10,000.00 -$3,000.00 $1,000.00

Discussion

No comments yet — be the first to weigh in on PTCT.

Sign in to join the discussion.

Scroll to Top